Effectiveness trials: critical data to help understand how respiratory medicines really work?

Area of Science:

• Respiratory Medicine
• Pharmacology
• Health Services Research

Background:

• Traditional efficacy studies like randomized controlled trials (RCTs) have limitations in reflecting real-world clinical practice.
• A gap exists in the utilization of effectiveness data for decision-making in the respiratory field, despite its potential.
• Advances in data management and analytics now enable routine use of effectiveness data.

Purpose of the Study:

• To examine current data gaps and diverse types of effectiveness data in respiratory medicine.
• To explore proposed frameworks for integrating effectiveness data into decision-making processes.
• To provide examples of past and ongoing effectiveness studies in respiratory therapeutic areas.

Main Methods:

• Review of existing literature on effectiveness data in respiratory medicine.
• Analysis of data capture, curation, storage, and analytical tools for generating Real World Evidence (RWE).
• Examination of case studies and ongoing research in respiratory therapeutic areas.

Main Results:

• Effectiveness data, including RWE, has the potential to supplement traditional efficacy data.
• Despite calls for RWE, its application in respiratory treatment decision-making remains limited.
• New technologies facilitate the routine collection and analysis of effectiveness data.

Conclusions:

• Effectiveness data can address critical evidentiary gaps concerning the effectiveness, safety, and value of respiratory treatments.
• Integrating RWE into decision-making can improve the understanding of treatments in real-world settings.
• Further research and framework development are needed to fully leverage effectiveness data in respiratory medicine.